TFGT
LVTX

TS Financial Group (TSFG)’s LAVA Therapeutics LVTX Stock Holding History

TS Financial Group (TSFG)’s Portfolio LVTX Stock Details LVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-400
Closed -$1K – 858
2025
Q3 		$1K Hold
400
– – ﹤0.01% 797
2025
Q2 		$1K Hold
400
– – ﹤0.01% 771
2025
Q1 		$1K Hold
400
– – ﹤0.01% 763
2024
Q4 		$0 Hold
400
– – ﹤0.01% 784
2024
Q3 		$1K Hold
400
– – ﹤0.01% 738
2024
Q2 		$1K Hold
400
– – ﹤0.01% 731
2024
Q1 		$1K Hold
400
– – ﹤0.01% 728
2023
Q4 		$1K Hold
400
– – ﹤0.01% 824
2023
Q3 		$1K Hold
400
– – ﹤0.01% 970
2023
Q2 		$1K Hold
400
– – ﹤0.01% 940
2023
Q1 		$1K Hold
400
– – ﹤0.01% 906
2022
Q4 		$1K Hold
400
– – ﹤0.01% 923
2022
Q3 		$2K Hold
400
– – ﹤0.01% 798
2022
Q2 		$1K Hold
400
– – ﹤0.01% 921
2022
Q1 		$2K Hold
400
– – ﹤0.01% 792
2021
Q4 		$2K Hold
400
– – ﹤0.01% 768
2021
Q3 		$2K Hold
400
– – ﹤0.01% 754
2021
Q2 		$4K Buy
+400
New +$4.96K ﹤0.01% 674

TS Financial Group (TSFG)'s LVTX Position: Q4 2025 in Review

TS Financial Group (TSFG) sold out of LAVA Therapeutics (LVTX) in Q4 2025, closing a stake of 400 shares — an estimated $1K sold.

TS Financial Group (TSFG) first reported a position in LVTX in Q2 2021 and held it in 18 quarters. The position peaked at $4K in Q2 2021. 0 funds tracked by Wall St. Rank hold LVTX as of Q4 2025.

  • TS Financial Group (TSFG) reported no remaining LAVA Therapeutics position as of Q4 2025 after selling out during the quarter.
  • TS Financial Group (TSFG) sold 400 LAVA Therapeutics shares in Q4 2025, an estimated $1K.
  • TS Financial Group (TSFG) first reported a position in LAVA Therapeutics in Q2 2021 and held it in 18 quarters.
  • TS Financial Group (TSFG)'s LAVA Therapeutics position peaked at $4K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held LAVA Therapeutics as of Q4 2025.

Based on TS Financial Group (TSFG)'s 13F filing for Q4 2025, filed 4 Feb 2026.